trial · primary record
vopimetostat
PDAC
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 188 |
| Primary completion | 2032-05 |
| Primary endpoint | Phase 1 Maximum Tolerated Dose |
| Registry ID | NCT07897734 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:19.148Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897734
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.